These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20298932)

  • 1. Effect of an antimicrobial agent on atherosclerotic plaques: assessment of metalloproteinase activity by molecular imaging.
    Ohshima S; Fujimoto S; Petrov A; Nakagami H; Haider N; Zhou J; Tahara N; Osako MK; Fujimoto A; Zhu J; Murohara T; Edwards DS; Narula N; Wong ND; Chandrashekhar Y; Morishita R; Narula J
    J Am Coll Cardiol; 2010 Mar; 55(12):1240-1249. PubMed ID: 20298932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy.
    Fujimoto S; Hartung D; Ohshima S; Edwards DS; Zhou J; Yalamanchili P; Azure M; Fujimoto A; Isobe S; Matsumoto Y; Boersma H; Wong N; Yamazaki J; Narula N; Petrov A; Narula J
    J Am Coll Cardiol; 2008 Dec; 52(23):1847-1857. PubMed ID: 19038682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.
    Haider N; Hartung D; Fujimoto S; Petrov A; Kolodgie FD; Virmani R; Ohshima S; Liu H; Zhou J; Fujimoto A; Tahara A; Hofstra L; Narula N; Reutelingsperger C; Narula J
    J Nucl Cardiol; 2009; 16(5):753-62. PubMed ID: 19662466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor.
    Ohshima S; Petrov A; Fujimoto S; Zhou J; Azure M; Edwards DS; Murohara T; Narula N; Tsimikas S; Narula J
    J Nucl Med; 2009 Apr; 50(4):612-7. PubMed ID: 19289429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early intervention on atherosclerosis by fluvastatin and lectin-like oxidized low-density lipoprotein receptor-1 expression in atherosclerotic arteries in immature rabbits].
    Yu YH; Wang Y; Chen Y; Liu ZZ; Sun SZ; Meng XH
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):762-6. PubMed ID: 16255856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages.
    Bellosta S; Via D; Canavesi M; Pfister P; Fumagalli R; Paoletti R; Bernini F
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1671-8. PubMed ID: 9812903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment.
    Kapelouzou A; Giaglis S; Peroulis M; Katsimpoulas M; Moustardas P; Aravanis CV; Kostakis A; Karayannakos PE; Cokkinos DV
    J Vasc Res; 2017; 54(3):156-169. PubMed ID: 28478461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells.
    Ikeda U; Shimpo M; Ohki R; Inaba H; Takahashi M; Yamamoto K; Shimada K
    Hypertension; 2000 Sep; 36(3):325-9. PubMed ID: 10988259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of MMP-9 activity in THP-1 cells by 7-ketocholesterol and its suppression by the HMG-CoA reductase inhibitor fluvastatin.
    Ozaki H; Miyashita Y; Watanabe H; Shirai K
    J Atheroscler Thromb; 2005; 12(6):308-14. PubMed ID: 16394614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy.
    Hartung D; Sarai M; Petrov A; Kolodgie F; Narula N; Verjans J; Virmani R; Reutelingsperger C; Hofstra L; Narula J
    J Nucl Med; 2005 Dec; 46(12):2051-6. PubMed ID: 16330569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of minocycline on carotid atherosclerotic plaques.
    Gao J; Gao X; Pan S
    Neurol Res; 2013 Oct; 35(8):844-50. PubMed ID: 23676309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin.
    Abe N; Osanai T; Fujiwara T; Kameda K; Matsunaga T; Okumura K
    Life Sci; 2006 Jan; 78(9):1021-8. PubMed ID: 16182316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits.
    Rikitake Y; Kawashima S; Takeshita S; Yamashita T; Azumi H; Yasuhara M; Nishi H; Inoue N; Yokoyama M
    Atherosclerosis; 2001 Jan; 154(1):87-96. PubMed ID: 11137086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive monitoring the biology of atherosclerotic plaque development with radiolabeled annexin V and matrix metalloproteinase inhibitor in spontaneous atherosclerotic mice.
    Tekabe Y; Li Q; Luma J; Weisenberger D; Sedlar M; Harja E; Narula J; Johnson LL
    J Nucl Cardiol; 2010 Dec; 17(6):1073-81. PubMed ID: 20700679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
    Rival Y; Benéteau N; Chapuis V; Taillandier T; Lestienne F; Dupont-Passelaigue E; Patoiseau JF; Colpaert FC; Junquéro D
    DNA Cell Biol; 2004 May; 23(5):283-92. PubMed ID: 15169608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits.
    Yang YP; Dong QL; Zhang XH; Zhang YH; Zhu L; Li SY; Liu ZZ; Xu H; Wang N; Jiang H; Liu CX; Liu XX; Dong B
    Acta Pharmacol Sin; 2011 Oct; 32(10):1259-65. PubMed ID: 21909126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
    Hu MY; Li YL; Jiang CH; Liu ZQ; Qu SL; Huang YM
    Nutrition; 2008 Oct; 24(10):1030-8. PubMed ID: 18585898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.